What are the next steps for liposomal chemotherapy delivery and CPX-351?
SPIRIT2 trial on dasatinib for AML - safety and side effect management
BTK inhibitors for relapsed mantle cell lymphoma: the new standard of care?
Side effects of idelalisib in CLL and how to manage them
INO-VATE trial of inotuzumab ozogamicin: response, efficacy and safety results